Research Paper Volume 15, Issue 18 pp 9779—9796
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 10. (A) Nomogram established for prognosis of PAAD. (B) Calibration curves for 1- and 3-year survival of PAAD. (C) Chemosensitivity of NDC1 in PAAD.